Home LiteratureArticle Details
PMID: 6327765 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Cellular defenses against Toxoplasma gondii in newborns.

The Journal of clinical investigation ·Vol. 73 ·No. 6 ·1984-06-00 ·Pages 1606-16

Wilson CB, Haas JE

Abstract

Mononuclear phagocytes, particularly macrophages (M phi) that have been activated by lymphokines, are the principal defense against intracellular pathogens such as Toxoplasma gondii. To determine reasons for the newborns' susceptibility to Toxoplasma infection, we compared: the interaction of Toxoplasma with newborns' mononuclear phagocytes (blood monocytes and two types of newborn M phi, those derived from blood monocytes or from placental tissue) with adults' blood monocytes and monocyte-derived M phi and the production of M phi-activating lymphokines (MAF) by Concanavalin A (ConA)-stimulated newborn and adult blood mononuclear cells (MC). Newborn and adult monocytes killed Toxoplasma with equal efficiency. Similarly, survival and replication of Toxoplasma were comparable in control newborn and adult M phi. Exposure to adult ConA supernatants significantly decreased the survival and replication of Toxoplasma both in adult and newborn M phi. In contrast, exposure to cord blood ConA supernatants failed to affect the survival or the replication of Toxoplasma in newborn M phi and decreased the replication but not the survival of Toxoplasma in adult M phi. Exposure to ConA supernatants of peripheral blood MC from 2-5-d old newborns failed to affect survival or replication of Toxoplasma in newborn or adult M phi. Thus, both generation of MAF by newborn blood MC and response to newborn MAF by newborn M phi were impaired. Generation of MAF by adult blood mononuclear cells was not inhibited by cord blood MC nor was generation of MAF by cord blood MC increased by depletion of OKT8 antibody-binding cells, by depletion of adherent cells with or without addition of adult adherent cells, or by addition of indomethacin. Depletion of OKT4 antibody-binding cells abrogated the generation of MAF both by adult and cord blood MC. The activity of adult ConA supernatants was abrogated by dialysis at pH 2 or by addition of anti-gamma-interferon but not anti-alpha-interferon antibody. However, the correlation between antiviral interferon activity and anti-Toxoplasma activity was weak (r = 0.40). Enhanced M phi anti-Toxoplasma activity was not associated with detectably enhanced superoxide anion generation, nitroblue tetrazolium reduction, or phagolysosome fusion, and was not inhibited by catalase, superoxide dismutase, or mannitol. These results indicate that generation of and response to MAF is decreased in cells from human newborns and that gamma-interferon may be the major MAF under these conditions.

MeSH Terms
Adult Cells, Cultured Concanavalin A Female Fetal Blood/physiology Fetus/immunology Fibroblasts/immunology Humans Immunity, Innate Infant, Newborn Lymphocytes/immunology Lymphokines/immunology Macrophage Activation Macrophages/immunology Monocytes/immunology Nitroblue Tetrazolium Pregnancy Superoxides/blood Toxoplasmosis/immunology
Chemicals
Lymphokines Concanavalin A Superoxides Nitroblue Tetrazolium
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Wilson C B
Haas J E
References (54)
54 references, click to expand
  1. Macrophages and age-dependent resistance to Herpes simplex virus in mice.
    J Immunol. 1970 May;104(5):1160-5 PMID: 4315461
  2. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.
    J Clin Invest. 1983 Oct;72(4):1506-10 PMID: 6415111
  3. A simple technique for eliminating interference by detergents in the Lowry method of protein determination.
    Anal Biochem. 1975 Mar;64(1):136-41 PMID: 1137083
  4. Lymphotoxin production and blast cell transformation by cord blood lymphocytes: dissociated lymphocyte function in newborn infants.
    Cell Immunol. 1974 Dec;14(3):435-42 PMID: 4549565
  5. Production of migration inhibitory factor and blast cell transformation by cord blood lymphocytes.
    Int Arch Allergy Appl Immunol. 1976;50(5):593-605 PMID: 773841
  6. Leucocyte migration inhibition factor (LIF) production by lymphocytes of normal children, newborns, and children with immune deficiency.
    Clin Exp Immunol. 1976 Jun;24(3):448-54 PMID: 133010
  7. Induction of resistance to Toxoplasma gondii in human macrophages by soluble lymphocyte products.
    J Immunol. 1976 Aug;117(2):381-7 PMID: 950460
  8. Chemotactic and bactericidal capacities of human newborn monocytes.
    J Immunol. 1976 Oct;117(4):1303-7 PMID: 977952
  9. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.
    J Exp Med. 1977 Dec 1;146(6):1719-34 PMID: 411876
  10. Aging and the immune response. II. Lymphocyte responsiveness and macrophage activation in Toxoplasma gondii-infected mice.
    J Immunol. 1978 Mar;120(3):944-9 PMID: 632594
  11. Monocyte function in human neonates.
    Infect Immun. 1978 Mar;19(3):898-902 PMID: 640736
  12. Mediation of immunity to intracellular infection (Toxoplasma and Besnoitia) within somatic cells.
    Infect Immun. 1978 Mar;19(3):999-1012 PMID: 640741
  13. Characterization of the effects of endotoxin on macrophage tumor cell killing.
    J Immunol. 1978 Jul;121(1):72-80 PMID: 27559
  14. Growth of herpes simplex and cytomegalovirus in cultured human alveolar macrophages.
    Am Rev Respir Dis. 1979 Feb;119(2):287-91 PMID: 219737
  15. Some physicochemical characteristics of an immune lymphocyte product which inhibits the multiplication of toxoplasma within mouse macrophages.
    Microbiol Immunol. 1979;23(1):17-30 PMID: 440144
  16. Human macrophage migration inhibition factor: evidence for subunit structure.
    Science. 1979 Jul 20;205(4403):300-1 PMID: 377487
  17. A method to evaluate the capacity of monocytes and macrophages to inhibit multiplication of an intracellular pathogen.
    J Immunol Methods. 1979 May 10;27(1):19-29 PMID: 379229
  18. Toxoplasma gondii: human interferon studies by plaque assay.
    Proc Soc Exp Biol Med. 1979 Sep;161(4):522-6 PMID: 482284
  19. Effects of monocytes from human neonates on lymphocyte transformation.
    Clin Exp Immunol. 1979 Jun;36(3):511-20 PMID: 487650
  20. Cellular (T cell) immunity in the human newborn.
    Pediatrics. 1979 Nov;64(5 Pt 2 Suppl):814-21 PMID: 159431
  21. Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates.
    J Exp Med. 1979 Oct 1;150(4):950-64 PMID: 512587
  22. Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens.
    J Exp Med. 1980 Feb 1;151(2):328-46 PMID: 7356726
  23. Immune competence of newborn lymphocytes.
    Pediatrics. 1980 Mar;65(3):491-6 PMID: 6244527
  24. Activity of human blood leukocytes against Toxoplasma gondii.
    J Infect Dis. 1979 Dec;140(6):890-5 PMID: 541523
  25. Toxicity and efficacy of human leukocyte interferon for treatment of cytomegalovirus pneumonia after marrow transplantation.
    J Infect Dis. 1980 May;141(5):555-62 PMID: 6154755
  26. Deficiency of immune interferon production by leukocytes of normal newborns.
    Cell Immunol. 1980 Sep 15;55(1):191-200 PMID: 6159105
  27. Macrophages in resistance to rickettsial infections: characterization of lymphokines that induce rickettsiacidal activity in macrophages.
    J Immunol. 1981 Jan;126(1):204-7 PMID: 7005333
  28. Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation.
    J Exp Med. 1980 Dec 1;152(6):1596-609 PMID: 6256463
  29. Macrophage oxygen-dependent antimicrobial activity. IV. Role of endogenous scavengers of oxygen intermediates.
    J Exp Med. 1980 Dec 1;152(6):1610-24 PMID: 7452149
  30. The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon.
    J Immunol. 1981 Mar;126(3):829-33 PMID: 6161964
  31. Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma).
    J Immunol. 1981 Apr;126(4):1620-3 PMID: 6162895
  32. Interferon induction of natural killer cytotoxicity in human neonates.
    J Pediatr. 1981 Mar;98(3):379-84 PMID: 6162936
  33. Production of leukocytic pyrogen from phagocytes of neonates.
    J Infect Dis. 1981 Oct;144(4):337-43 PMID: 7288214
  34. Characterization of the suppressor cell activity in human cord blood lymphocytes.
    J Clin Invest. 1981 Dec;68(6):1577-85 PMID: 6172447
  35. Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response.
    J Immunol. 1982 Jan;128(1):123-8 PMID: 6274954
  36. Requirement for OKT8+ suppressor cell proliferation for suppression by human newborn T cells.
    Clin Exp Immunol. 1981 Sep;45(3):468-74 PMID: 6461445
  37. Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes.
    J Clin Invest. 1982 May;69(5):1099-111 PMID: 7068848
  38. Studies of the cell lineage of the effector cells that spontaneously lyse HSV-1 infected fibroblasts (NK(HSV-1)).
    J Immunol. 1982 Aug;129(2):824-8 PMID: 7086145
  39. Leukocyte function in healthy neonates following vaginal and cesarean section deliveries.
    J Pediatr. 1982 Aug;101(2):269-72 PMID: 7097427
  40. Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus.
    J Clin Invest. 1982 Oct;70(4):762-8 PMID: 6288769
  41. Similarities of murine gamma interferon and the lymphokine that renders macrophages cytotoxic.
    J Interferon Res. 1982;2(2):291-9 PMID: 6811671
  42. Effects of muramyl dipeptide on superoxide anion release and on anti-microbial activity of human macrophages.
    Clin Exp Immunol. 1982 Aug;49(2):371-6 PMID: 6290115
  43. Lymphokines enhance the capacity of human monocytes to secret reactive oxygen intermediates.
    J Clin Invest. 1982 Nov;70(5):1042-8 PMID: 7130393
  44. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
    J Immunol. 1982 Dec;129(6):2802-7 PMID: 6982943
  45. Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.
    J Immunol. 1983 Apr;130(4):1784-9 PMID: 6403613
  46. Isolation, purification and characteristics of mononuclear phagocytes from human placentas.
    J Immunol Methods. 1983 Feb 11;56(3):305-17 PMID: 6300249
  47. Inhibition of the growth of Rickettsia prowazekii in cultured fibroblasts by lymphokines.
    J Exp Med. 1983 Mar 1;157(3):974-86 PMID: 6403652
  48. Interferonlike factors from antigen- and mitogen-stimulated human leukocytes with antirickettsial and cytolytic actions on Rickettsia prowazekii. Infected human endothelial cells, fibroblasts, and macrophages.
    J Exp Med. 1983 Jun 1;157(6):1780-93 PMID: 6189947
  49. How protozoa evade intracellular killing.
    Ann Intern Med. 1983 Jun;98(6):1016-8 PMID: 6344706
  50. Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon.
    J Immunol. 1983 Aug;131(2):826-32 PMID: 6408190
  51. Lymphokine enhances oxygen-independent activity against intracellular pathogens.
    J Exp Med. 1983 Jul 1;158(1):234-9 PMID: 6864162
  52. Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity.
    J Clin Invest. 1983 Jul;72(1):32-44 PMID: 6308049
  53. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
    J Exp Med. 1983 Sep 1;158(3):670-89 PMID: 6411853
  54. Inhibition of multiplication of Toxoplasma gondii by human monocytes exposed to T-lymphocyte products.
    J Exp Med. 1975 Feb 1;141(2):483-96 PMID: 1089746
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1984-06-00
Pages
1606-16
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC437071
Subset
IM
Grants
NICHD NIH HHS · HD/AI 18184 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com